Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Mead Johnson Nutrition Company has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners across 2 distinct art units, indicating examiner separation with some art-unit repetition.
LEBLANC, KATHERINE DEGUIRE is the busiest examiner, with 1 pending matter. Counsel should use art-unit context where relevant, while maintaining separate examiner-specific analysis for each matter.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEBLANC, KATHERINE DEGUIRE | 1 | 34.6% | +36.0% |
| DURYEE, ALEXANDER MARSH | 1 | 33.3% | +41.7% |
| MCNEIL, JENNIFER C | 1 | 23.7% | +20.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18558050 | NUTRITIONAL COMPOSITIONS FOR HUMAN CONSUMPTION AND METHODS FOR MAKING SAME | MCNEIL, JENNIFER C | 12d |
| 18581744 | WELLBEING SUPPLEMENT FOR POSTPARTUM MATERNAL NUTRITION | DURYEE, ALEXANDER MARSH | 27d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18558050 | NUTRITIONAL COMPOSITIONS FOR HUMAN CONSUMPTION AND METHODS FOR MAKING SAME | MCNEIL, JENNIFER C | 12d |
| 18581744 | WELLBEING SUPPLEMENT FOR POSTPARTUM MATERNAL NUTRITION | DURYEE, ALEXANDER MARSH | 27d |
| 19003955 | PEDIATRIC NUTRITIONAL COMPOSITIONS AND METHODS FOR INFANTS DELIVERED BY C-SECTION | LEBLANC, KATHERINE DEGUIRE | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| 1723 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19003955 | PEDIATRIC NUTRITIONAL COMPOSITIONS AND METHODS FOR INFANTS DELIVERED BY C-SECTION | LEBLANC, KATHERINE DEGUIRE | — | §103 | Non-Final OA | — | Pending | Dec 27, 2024 |
| 18581744 | WELLBEING SUPPLEMENT FOR POSTPARTUM MATERNAL NUTRITION | DURYEE, ALEXANDER MARSH | 1657 | §103§112 | Final Rejection | 27d | Pending | Feb 20, 2024 |
| 18558050 | NUTRITIONAL COMPOSITIONS FOR HUMAN CONSUMPTION AND METHODS FOR MAKING SAME | MCNEIL, JENNIFER C | 1723 | Other | Final Rejection | 12d | Pending | Oct 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMead Johnson Nutrition Company has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Katherine Deguire Leblanc has the most, with 1 of Mead Johnson Nutrition Company's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
